483 Brightgene Pharmaceutical Sep 2015

483 Brightgene Pharmaceutical Sep 2015

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Brightgene Pharmaceutical - Suzhou, China facility and issued 7 inspectional observations (via FDA 483) on 10 Sep 2015.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 7
  • Inspection end: 10 Sep 2015
  • Location: Suzhou, China
  • FEI: 3009867839
Add To Cart